Merck Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Tepotinib Drug-Drug Interaction Study With Carbamazepine in Healthy Participants
Condition:   Healthy Interventions:   Drug: Tepotinib Hydrochloride Hydrate;   Drug: Carbamazepine Sponsor:   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials